IMA is loading

Main Financial Data 2003

Main Data: 31/12 Year 2003
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 351.33
– gross margin 149.54
– total operating cost 105.21
– net operating profit 39.25
– financial expenses, netv 4.01
– net income before taxes 18.96

 

Consolidated balance sheet Millions/Euro
– operating capital 78.20
– fixed assets, net 102.14
– reserves and MLT non financial payables – 13.74
– net financial position – 68.49
– stockholders’ equity 98.11

 

Other Information Millions/Euro
– depreciation 15.65
– R & D expenses 18.21

 

  Euro
Dividend per share 0.40

 

  No.
Employees 2,400

 

  Euro
Shares outstanding 18,772,000

 

Main Data: 30/06 Year 2003
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 143.72
– gross margin 57.82
– total operating cost 54.03
– net operating profit 1.24
– financial expenses, net 0.18
– net income before taxes 0.45

 

Consolidated balance sheet Millions/Euro
– operating capital 92.46
– fixed assets, net 103.05
– reserves and MLT non financial payables – 14.91
– net financial position 85.77
– stockholders’ equity 94.83

 

Other information Millions/Euro
– depreciation 7.58
– R & D expenses 9.60

 

  No.
Employees 2,382

 

  Euro
Shares outstanding 18,772,000

 

Net Sales by Sector: Year 2003
  Millions/Euro  
tea, herbs & coffee 56.96 16.21%
pharmaceuticals packaging 208.52 59.35%
pharmaceuticals processing 85.85 24.44%
Total 351.33 100.00%

 

Net Sales by Country: Year 2003
  Millions/Euro  
E.U. (excluding Italy) 146.56 41.72%
Other European countries 37.37 10.64%
North America 71.86 20.45%
Asia & Middle East 37.36 10.63%
Other countries 28.92 8.23%
Total exports 322.07 91.67%
Italy 29.26 8.33%
Total 351.33 100.00%